Literature DB >> 11897102

Bilirubin produces apoptosis in cultured bovine brain endothelial cells.

E Akin1, B Clower, R Tibbs, J Tang, J Zhang.   

Abstract

Blood components such as oxyhemoglobin are believed to cause cerebral vasospasm by inducing contraction and cell death in cerebral arteries. We have observed previously that oxyhemoglobin produces apoptotic changes in cultured endothelial cells. This study was undertaken to explore if bilirubin, a bi-product of hemoglobin degradation, will produce similar cytotoxicity in endothelial cells. Cultured bovine brain microvascular endothelial cells were incubated in four concentrations of bilirubin (10, 25, 50, and 100 microM) for varying times (6, 12, and 24 h). Control cells were incubated in saline or vehicle (NaOH solution, <0.01% of 0.01 N) for similar time periods. The cultured cells were then observed microscopically for evidence of cellular alterations. Bilirubin (10-100 microM) produced apoptosis that appeared time-dependent but not clearly concentration-dependent. Biochemical markers for apoptosis such as DNA fragmentation and PARP cleavage were induced by bilirubin. We conclude that endothelial cells may undergo apoptosis after exposure to bilirubin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897102     DOI: 10.1016/s0006-8993(02)02276-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  The jaundice of the cell.

Authors:  David A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

Review 2.  Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns.

Authors:  Jon F Watchko
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Bilirubin increases the expression of glucose transporter-1 and the rate of glucose uptake in vascular endothelial cells.

Authors:  Guy Cohen; Dan M Livovsky; Jaime Kapitulnik; Shlomo Sasson
Journal:  Rev Diabet Stud       Date:  2006-11-10

4.  Transport and metabolism at blood-brain interfaces and in neural cells: relevance to bilirubin-induced encephalopathy.

Authors:  Silvia Gazzin; Nathalie Strazielle; Claudio Tiribelli; Jean-François Ghersi-Egea
Journal:  Front Pharmacol       Date:  2012-05-18       Impact factor: 5.810

5.  Time-dependent dual effects of high levels of unconjugated bilirubin on the human blood-brain barrier lining.

Authors:  Inês Palmela; Hiroyuki Sasaki; Filipa L Cardoso; Miguel Moutinho; Kwang S Kim; Dora Brites; Maria A Brito
Journal:  Front Cell Neurosci       Date:  2012-05-10       Impact factor: 5.505

6.  Endothelial Cells Derived from the Blood-Brain Barrier and Islets of Langerhans Differ in their Response to the Effects of Bilirubin on Oxidative Stress Under Hyperglycemic Conditions.

Authors:  Jaime Kapitulnik; Clara Benaim; Shlomo Sasson
Journal:  Front Pharmacol       Date:  2012-07-13       Impact factor: 5.810

7.  Evaluating the beneficial and detrimental effects of bile pigments in early and later life.

Authors:  Phyllis A Dennery
Journal:  Front Pharmacol       Date:  2012-06-22       Impact factor: 5.810

8.  Hydrophilic bile acids protect human blood-brain barrier endothelial cells from disruption by unconjugated bilirubin: an in vitro study.

Authors:  Inês Palmela; Leonor Correia; Rui F M Silva; Hiroyuki Sasaki; Kwang S Kim; Dora Brites; Maria A Brito
Journal:  Front Neurosci       Date:  2015-03-13       Impact factor: 4.677

9.  Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells.

Authors:  Filipa L Cardoso; Agnes Kittel; Szilvia Veszelka; Inês Palmela; Andrea Tóth; Dora Brites; Mária A Deli; Maria A Brito
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

10.  Endogenous Tetrapyrroles Influence Leukocyte Responses to Lipopolysaccharide in Human Blood: Pre-Clinical Evidence Demonstrating the Anti-Inflammatory Potential of Biliverdin.

Authors:  Kavita Bisht; Jens Tampe; Cecilia Shing; Bhavisha Bakrania; James Winearls; John Fraser; Karl-Heinz Wagner; Andrew C Bulmer
Journal:  J Clin Cell Immunol       Date:  2014-05-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.